Bromopyruvate

Bromopyruvate

SCHEMBL5176091

O=C(O)C(=O)CBr.[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromopyruvate SCHEMBL8126 0.96
Bromopyruvate SCHEMBL28744745 0.93
Bromopyruvate SCHEMBL272971 0.93
Bromopyruvate SCHEMBL28515628 0.84 TSHR (0.42)
Bromopyruvate SCHEMBL5175787 0.80 OR51E2 (0.41)
SCHEMBL180158 0.76
Bromoacetic Acid SCHEMBL27365548 0.72
Bromoacetic Acid SCHEMBL5492312 0.69 CA4 (0.47)
Bromoacetic Acid SCHEMBL28837801 0.69 TSHR (0.83)
SCHEMBL5799291 0.69 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786411-A2 3-HALO-2-OXOPROPIONATE SALTS AND ESTERS AS NOVEL ANTICANCER AGENTS Board of Regents, The University of Texas System (US) 2007-05-23 EP disclosed
US-20060058383-A1 Propyl 3-bromo-2-oxopropionate and derivatives as novel anticancer agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2006-03-16 US disclosed
WO-2006020403-A2 3-HALO-2-OXOPROPIONATE SALTS AND ESTERS AS NOVEL ANTICANCER AGENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2006-02-23 WO disclosed
US-5543298-A ADDING SPECIFIED COMPOUND TO LIQUID SAMPLE, MEASURING RATE OF AUTOOXIDATION SPECTROPHOTOMETRICALLY OXIS INTERNATIONAL S.A. (FR) 1996-08-06 US disclosed